Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aoki, M.
Right arrow Articles by Murohara, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aoki, M.
Right arrow Articles by Murohara, T.

Stem Cells 2004;22:994-1002 www.StemCells.com
© 2004 AlphaMed Press

Derivation of Functional Endothelial Progenitor Cells from Human Umbilical Cord Blood Mononuclear Cells Isolated by a Novel Cell Filtration Device

Mika Aokia, Mikitomo Yasutakeb, Toyoaki Muroharaa

a Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan;
b R&D Laboratories,Asahi Kasei Medical Co., Ltd., Tokyo, Japan

Key Words. Angiogenesis • Cord blood • Endothelium • Progenitor cell

Correspondence: Toyoaki Murohara, M.D., Ph.D., Department of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan. Telephone: 81-52-744-2149; Fax: 81-52-744-2157; e-mail: muro-hara{at}med.nagoya-u.ac.jp

Endothelial progenitor cells (EPCs) can differentiate from mononuclear cells (MNCs) of adult human peripheral blood, bone marrow, and cord blood during culture. Although MNCs are usually isolated by a Ficoll gradient centrifuge method, this method is time-consuming, and blood is easily contaminated. We developed a novel cell filtration device (StemQuickTME, Asahi Kasei Medical, Oita, Tokyo, Japan) to isolate MNCs from human cord blood and examined whether functional EPCs could differentiate from MNCs isolated by this device. Recovery rates of MNCs, CD34+ and CD133+ progenitor cells, were significantly greater in the StemQuickTME method than in the Ficoll method. During MNC culture, spindle-shaped attaching cells developed, and most of these cells incorporated DiI-acetylated low-density lipoprotein and showed positive binding to fluorescein isothiocyanate–lectin. Reverse transcription–polymerase chain reaction analysis revealed that attaching cells expressed various progenitor and endothelial lineage markers such as KDR, CD31, endothelial cell nitric oxide synthase, CD133, and LOX-1. Culture-expanded EPCs were isolated and labeled with a green fluorescent dye, PKH2-GL, and cocultured with human umbilical vein endothelial cells (HUVECs). EPCs formed angiogenesis-like networks together with HUVECs in 3D matrix gel. Finally, EPCs (3 x 105) were implanted into ischemic hindlimb of nude rats (n = 3), and laser Doppler blood flowmetry (LDBF) revealed that the ratio of ischemic to normal limb LDBF was significantly greater in EPC-transplanted animals compared with controls receiving saline. In conclusion, the novel cell filtration device, StemQuickTME, is a useful tool to isolate MNCs from human cord blood. Moreover, MNCs obtained by this filter system can give rise to functional EPCs.




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
D. Tang, J. Lu, J. P. Walterscheid, H.-H. Chen, D. A. Engler, T. Sawamura, P.-Y. Chang, H. J. Safi, C.-Y. Yang, and C.-H. Chen
Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1
J. Lipid Res., January 1, 2008; 49(1): 33 - 47.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. C. Partlow, J. Chen, J. A. Brant, A. M. Neubauer, T. E. Meyerrose, M. H. Creer, J. A. Nolta, S. D. Caruthers, G. M. Lanza, and S. A. Wickline
19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons
FASEB J, June 1, 2007; 21(8): 1647 - 1654.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Ma, Y. Ladilov, J. M. Moebius, L. Ong, C. Piechaczek, A. David, A. Kaminski, Y.-H. Choi, W. Li, D. Egger, et al.
Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: Bone marrow vs. cord blood-derived cells
Cardiovasc Res, July 1, 2006; 71(1): 158 - 169.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Egami, T. Murohara, M. Aoki, and T. Matsuishi
Ischemia-induced angiogenesis: role of inflammatory response mediated by P-selectin
J. Leukoc. Biol., May 1, 2006; 79(5): 971 - 976.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
E. Rohde, C. Malischnik, D. Thaler, T. Maierhofer, W. Linkesch, G. Lanzer, C. Guelly, and D. Strunk
Blood Monocytes Mimic Endothelial Progenitor Cells
Stem Cells, February 1, 2006; 24(2): 357 - 367.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Lee, M. Aoki, T. Kondo, K. Kobayashi, K. Okumura, K. Komori, and T. Murohara
Therapeutic Angiogenesis With Intramuscular Injection of Low-Dose Recombinant Granulocyte-Colony Stimulating Factor
Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2535 - 2541.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2004 by AlphaMed Press.